OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
18
Results
Show all
Save search
Copy query
Show results for
Unknown
(18)
Publication Date
Release Date
2023
(4)
2020
(4)
2025
(3)
2024
(3)
2022
(2)
2018
(1)
2015
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
CircMIB1 inhibits glioma development and progression through a competing endogenous RNA interaction network.
Not available
S-EPMC11652353
|
biostudies-literature
Cite
Naphthoquinone-derived ZSW-4B induces apoptosis in triple-negative breast cancer via AMPK signalling activation.
Not available
S-EPMC11574302
|
biostudies-literature
Cite
De novo CHD7 variant in a CHARGE syndrome preterm infant initially diagnosed as idiopathic hypogonadotropic hypogonadism: a case report and literature review.
Not available
S-EPMC12613921
|
biostudies-literature
Cite
Elevated Expression of Serum Endothelial Cell Adhesion Molecules in COVID-19 Patients.
Not available
S-EPMC7337874
|
biostudies-literature
Cite
Effects of
Litsea cubeba
essential oil on growth performance, blood antioxidation, immune function, apparent digestibility of nutrients, and fecal microflora of pigs.
Not available
S-EPMC10350539
|
biostudies-literature
Cite
Severe delayed pulmonary toxicity following PD-L1-specific CAR-T cell therapy for non-small cell lung cancer.
Not available
S-EPMC7546952
|
biostudies-literature
Cite
Machine Learning Algorithms Identify Clinical Subtypes and Cancer in Anti-TIF1γ+ Myositis: A Longitudinal Study of 87 Patients.
Not available
S-EPMC8883045
|
biostudies-literature
Cite
Improved USER cloning for TALE assembly and its application to base editing.
Not available
S-EPMC10403120
|
biostudies-literature
Cite
Analysis of redox landscapes and dynamics in living cells and in vivo using genetically encoded fluorescent sensors.
Not available
S-EPMC6714056
|
biostudies-literature
Cite
PD-1/ PD-L1 bispecific antibody IBI318 combined with lenvatinib in advanced non-small cell lung cancer with acquired resistance to immune checkpoint inhibitors: a phase II trial.
Not available
S-EPMC12808239
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets